Binge Eating Disorder Clinical Trials 2023

Binge Eating Disorder Clinical Trials 2023

Binge Eating Disorder research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in binge eating disorder clinical trials today.

Trials for BED Patients

Trials for Obesity Patients

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to binge eating disorder

What are the top hospitals conducting binge eating disorder research?

When it comes to the battle against binge eating disorder (BED), several prestigious hospitals are leading the way in clinical trials. In Philadelphia, Drexel University's Stratton Hall is at the forefront of cutting-edge research with three active BED trials and a total of five conducted studies on this condition. Their commitment to finding solutions for BED dates back to their first recorded trial in 2018. Meanwhile, Yale Department of Psychiatry in New Haven stands shoulder-to-shoulder with Drexel, conducting three ongoing BED trials and having completed four previous investigations since pioneering their initial study in 2007.

Notably, Lindner Center of HOPE located in Mason has made significant contributions to understanding and treating BED as well. With two active clinical trials underway and an impressive history of eight prior studies spanning from its inaugural investigation dating back to 2006, this center continues to push boundaries for better outcomes for individuals affected by this disorder.

Philadelphia's main campus at Drexel University also plays a crucial role in addressing the challenges posed by binge eating disorder. Although currently focusing on one active trial, they have demonstrated their dedication through six past investigations initiated as early as 2015.

Lastly but certainly not least important is The Yale Medical School Department of Psychiatry situated within New Haven; while still new entrants into researching about Binge Eating Disorder(BED) they show tremendous promise with one ongoing trial commencing just recently alongwith giving out effort towards enabling positive change for numerous affected patients already seen working towards ensuring sustainable support mechanisms starting from2022

These esteemed institutions symbolize hope for those battling binge eating disorder - offering new possibilities through innovative treatments and interventions rooted firmly within evidence-based research. As these hospitals continue their efforts collectively or individually across locations nationwide,this provides assurance that no stone will be left unturned until we discover effective methods not only managing but overcoming Binge Eating Disorders

Which are the best cities for binge eating disorder clinical trials?

When it comes to clinical trials for binge eating disorder, several cities are at the forefront of research. Philadelphia, Pennsylvania and New Haven, Connecticut each have 4 active trials focused on interventions such as Cognitive Behavioral Therapy (CBT), Mindful Awareness, and medication options like LDX and Naltrexone/Bupropion. Mason, Ohio follows closely with 3 ongoing trials exploring treatments like light therapy and medications such as Solriamfetol and Lisdexamfetamine. Additionally, Hamilton in Ontario offers one trial centered around a self-compassionate letter-writing intervention while Belmont in Massachusetts focuses on a Talking Activity intervention. These cities provide individuals struggling with binge eating disorder access to groundbreaking clinical trials that aim to improve understanding and treatment approaches for this challenging condition.

Which are the top treatments for binge eating disorder being explored in clinical trials?

In the realm of clinical trials for binge eating disorder treatments, two notable contenders have emerged. One is Behavioral Therapy for Eating Disorders, currently involved in one active trial and a total of two all-time trials dedicated to addressing binge eating disorder. This treatment approach made its debut in 2020 and shows promise in helping individuals overcome this challenging condition. Another option being explored is Cognitive behavioral therapy guided self-help (CBTgsh), which entered the scene more recently in 2022. It too has one ongoing trial specifically targeting binge eating disorder, showcasing its potential as an effective intervention method. As researchers delve deeper into these therapies, hope grows stronger for improved outcomes among those affected by binge eating disorder.

What are the most recent clinical trials for binge eating disorder?

Recent clinical trials have shed light on potential breakthroughs for individuals struggling with binge eating disorder. Psychotherapy has emerged as a promising avenue, showing positive results in Phase 2 studies conducted since March 2022. Additionally, solriamfetol, which completed its Phase 4 trial by June 2021, holds promise as a treatment option. Another innovative approach involves combining morning light exposure and melatonin supplementation to address this disorder—an intervention that has progressed through Phases 1 and 2 since January 2021. Furthermore, the Space From Body and Eating Concerns-Teen program aims to provide support specifically tailored for adolescents dealing with binge eating disorder following their successful completion of Phase 1 testing in December 2020. Lastly, naltrexone and bupropion showcased potential benefits during their combined Phase 2/Phase3 trial period ending in August 2019. These recent clinical trials offer hope for individuals affected by this challenging condition while paving the way for improved treatments moving forward.

What binge eating disorder clinical trials were recently completed?

Recently, several clinical trials investigating treatments for binge eating disorder have reached completion, providing valuable insights into this complex condition. In February 2021, Idorsia Pharmaceuticals Ltd. successfully concluded a trial examining the potential of ACT-539313 as a therapeutic option. Additionally, in April 2018, Yale University completed a trial evaluating the effectiveness of Bupropion Hydrochloride and Naltrexone Hydrochloride Drug Combination. Prior to that, in September 2017 and August 2017 respectively, Yale University wrapped up two separate trials involving NB medication (Naltrexone Bupropion combination). Lastly, in February 2017, another trial focusing on NB medication (Naltrexone Bupropion combination) was also completed at Yale University. These important studies contribute significantly to our understanding and treatment options for individuals with binge eating disorder.